Search

9 results for “monoclonal antibody”

• Review ArticleOpen Access

  Rituximab, a Safer Option for Rheumatoid Arthritis: A Comparison of the Reported Adverse Events of Approved Monoclonal Antibodies

  Sweety Sharma, Somnath Basu, Ramesh K. Goyal, Parbhat K. Sahoo, Rajani Mathur

  Vol. 13 · Issue 4 · pp. 330–340

  https://doi.org/10.1177/0976500X231154743
  Full text ↗PDF

• Review ArticleOpen Access

  Efficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis

  Marianne Frieri, William Heuser, Joshua Bliss

  Vol. 6 · Issue 2 · pp. 71–76

  https://doi.org/10.4103/0976-500X.155482
  Full text ↗PDF

• Case ReviewOpen Access

  Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review

  Christian Leporini, Francesca Saullo, Gianfranco Filippelli, Antonio Sorrentino, Maria Lucia, Gino Perri, Gaetana Gattuta, Stefania Infusino, Rosa Toscano, Gianluca Dima, Virginia Olivito, Laura Paletta, Ugo Bottoni, Giovambattista Sarro

  Vol. 4 · Issue Supplement 1 · pp. S78–S79

  https://doi.org/10.4103/0976-500X.120966
  Full text ↗PDF

• Review ArticleOpen Access

  Secukinumab: A Silver Lining in Dermatology

  Dhanaraj Manoharan, Ravi Vignesh N., Srinivasan Shreya, Saravanan Suzsmi L.

  Vol. 13 · Issue 2 · pp. 119–124

  https://doi.org/10.1177/0976500X221105921
  Full text ↗PDF

• Research ArticleOpen Access

  Systematic Review and Meta-Analysis Comparing the Safety of Natalizumab, Ocrelizumab, and Alemtuzumab in Treating Relapsing–Remitting, Primary Progressive, and Secondary Progressive Multiple Sclerosis

  Pooja Raina, Somnath Basu, Ramesh K Goyal, Pravat K Sahoo, Rajani Mathur

  Vol. 13 · Issue 1 · pp. 14–23

  https://doi.org/10.1177/0976500X221080225
  Full text ↗PDF

• Research LetterOpen Access

  Penetration of Bromelain in Serum and Rhinosinusal Mucosa in Patients Undergoing Endoscopic Sinus Surgery

  Desiderio Passali, Luisa Maria Bellussi, Codrut Sarafoleanu, Michele Loglisci, Claudiu Manea, Cristina Iosif, Francesco Maria Passali

  Vol. 8 · Issue 3 · pp. 128–9

  https://doi.org/10.4103/jpp.JPP_169_16
  Full text ↗PDF

• Molecules of MillenniumOpen Access

  Proprotein convertase subtilisin/kexin type 9 enzyme inhibitors: An emerging new therapeutic option for the treatment of dyslipidemia

  Faizan Mazhar, Nafis Haider

  Vol. 7 · Issue 4 · pp. 190–3

  https://doi.org/10.4103/0976-500X.195906
  Full text ↗PDF

• Review ArticleOpen Access

  Red carpeting the newer antidiabetics

  Dilip Gude

  Vol. 3 · Issue 2 · pp. 127–131

  https://doi.org/10.4103/0976-500X.95507
  Full text ↗PDF

• Molecules of the MillenniumOpen Access

  Belatacept: A worthy alternative to cyclosporine?

  George Melvin, Selvarajan Sandhiya, Kumaresan Subraja

  Vol. 3 · Issue 1 · pp. 90–92

  https://doi.org/10.4103/0976-500X.92499
  Full text ↗PDF